Review of Descending Aortic Flow Reversal in Total Anomalous Pulmonary Venous Connection
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This is a retrospective review of charts and echocardiograms of our patients with Total Anomalous Pulmonary Venous Connection (TAPVC). The Children's Surgical and non-invasive Echo databases will be used to determine all TAPVC patients. Children's Healthcare of Atlanta and Sibley Heart Center Cardiology charts and echocardiograms of the TAPVC patients between January 1, 2002 and November 26, 2006 will be reviewed. We anticipate approximately 40 patients.
We hypothesize that the presence of descending aortic flow reversal correlates with a higher morbidity and mortality in TAPVC.
| Condition |
|---|
|
Congenital Disorders |
| Study Type: | Observational |
| Study Design: | Time Perspective: Retrospective |
| Official Title: | Proposal for Retrospective Review of Descending Aortic Flow Reversal in Total Anomalous Pulmonary Venous Connection |
| Estimated Enrollment: | 40 |
| Study Start Date: | December 2006 |
| Study Completion Date: | September 2007 |
Total anomalous pulmonary venous connection (TAPVC) is a congenital cardiac anomaly in which the pulmonary veins fail to connect to the usual anatomic location, the left atrium. This may lead to critical cardio-pulmonary failure and extreme cyanosis. This condition usually requires urgent surgical repair. In many cases, the pulmonary veins may be obstructed leading to severe pulmonary hypertension and low cardiac output which may be acutely life-threatening. In these cases, emergent surgical repair is undertaken in the newborn period. Patients with TAPVC may have poor prognosis which may be difficult to predict.
We have made the unusual and previously unreported observation by echocardiography of flow reversal in the upper descending aorta, indicating extremely reduced left ventricular output in patients with TAPVC, some of whom have had a poor outcome. This has led to the hypothesis that descending aortic flow reversal portends a poor prognosis in TAPVC.
The patients with TAPVC will be divided into two groups by the presence or absence of descending aortic flow reversal. We, also, would evaluate the presence of other associated cardiac anomalies.
The second step of the study would be to review the clinical charts of the above patients to evaluate for serious co-morbidities and mortality. Outcome measures would include mortality, chronic lung disease, continued oxygen requirement, recurrent respiratory infections, listing for transplantation, cardiopulmonary arrest or requirement for ECMO.
Eligibility| Ages Eligible for Study: | up to 21 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
TAPVC patients
Inclusion Criteria:
- Children's Healthcare of Atlanta and Sibley Heart Center Cardiology charts and echocardiograms of the TAPVC patients between January 1, 2002 and November 26, 2006 will be reviewed. We anticipate approximately 40 patients.
The patients with TAPVC will be divided into two groups by the presence or absence of descending aortic flow reversal.
Exclusion Criteria:
- those who do not fall under the Inclusion Criteria
Contacts and Locations| United States, Georgia | |
| Children's Healthcare of Atlanta | |
| Atlanta, Georgia, United States, 30322 | |
| Principal Investigator: | Derek A Fyfe, MD, PhD | Sibley Heart Center Cardiology at Children's Healthcare of Atlanta |
More Information
No publications provided
| Responsible Party: | Director Research, Children's Healthcare of Atlanta Institutional Review Board |
| ClinicalTrials.gov Identifier: | NCT00486070 History of Changes |
| Other Study ID Numbers: | 06-197 |
| Study First Received: | June 12, 2007 |
| Last Updated: | March 14, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Children's Healthcare of Atlanta:
|
cardiac anomaly pulmonary veins cyanosis flow reversal TAPAVC |
Additional relevant MeSH terms:
|
Scimitar Syndrome Lung Diseases Respiratory Tract Diseases Respiratory System Abnormalities Vascular Malformations |
Cardiovascular Abnormalities Cardiovascular Diseases Vascular Diseases Congenital Abnormalities |
ClinicalTrials.gov processed this record on May 21, 2013